Cocrystal Pharma, Inc. (NASDAQ:COCP) Short Interest Update

Cocrystal Pharma, Inc. (NASDAQ:COCP) was the target of a large decrease in short interest in November. As of November 30th, there was short interest totalling 7,000 shares, a decrease of 12.5% from the November 15th total of 8,000 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily volume of 18,600 shares, the short-interest ratio is presently 0.4 days.

Analysts Set New Price Targets

Separately, HC Wainwright dropped their price objective on shares of Cocrystal Pharma from $10.00 to $7.00 and set a “buy” rating on the stock in a research note on Thursday, August 22nd.

Cocrystal Pharma Price Performance

Shares of COCP stock opened at $1.91 on Friday. The stock has a 50 day simple moving average of $1.94 and a 200-day simple moving average of $2.02. Cocrystal Pharma has a 1-year low of $1.33 and a 1-year high of $3.10. The company has a market cap of $19.41 million, a price-to-earnings ratio of -1.03 and a beta of 1.52.

About Cocrystal Pharma

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.